by Peggy Baker | Jul 11, 2021 | Policy, President's Notes
Harry J. Gould, III, MD, PhD On June 26, 2021, Johnson & Johnson confirmed that in 2020, as part of a $230M settlement with the State of New York, they discontinued promotion and distribution of opioid products in the State of New York. The settlement was made in...
